Publication | Closed Access
Penetration of Clindamycin into Bone in Man
20
Citations
0
References
1972
Year
OsteopathyAntibiotic AdjuvantBactericidal ActivitySurgeryAntimicrobial ChemotherapyOsteoporosisOrthopaedic SurgeryDrug ResistanceBone DiseaseSkeletal TraumaOsteoarthritisInfection ControlAntimicrobial ResistanceHealth SciencesRoutine Clinical PracticeAntimicrobial CompoundClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsPreliminary ResultsMedicineProsthetic Joint Infections
Clindamycin (7-chloro-7-deoxylincomycin-hydrochloride-monohydrate) is an antibiotic with a remarkable bacteriostatic and bactericidal activity against staphylococci [1, 4, 5, 8]. It may, therefore, be regarded as one of the drugs suited for therapy of staphylococcal osteomyelitis, especially after very good efficacy of Lincomycin was recorded in this disease. To confirm this assumption, however, the data on penetration of Clindamycin into the bone under conditions of routine clinical practice are needed above all. This study presents the preliminary results obtained in this respect.